Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
VERO BEACH, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies, today...
-
Myriad announced select unaudited preliminary results for the 4th quarter and full year ended Dec. 31, 2025, provided full year 2026 financial guidance.
-
Sam Raha, president and CEO of Myriad, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Jan. 14, at 5:15 pm PT.
-
InnovAge Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference
-
Alignment Healthcare, Inc. (NASDAQ: ALHC) will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 14, at 10:30 a.m. PST.
-
Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
ST. LOUIS, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that the...
-
Myriad Genetics management will participate in two upcoming healthcare conferences.
-
AC Immune to Present at the Jefferies 2025 London Healthcare Conference Lausanne, Switzerland, November 11, 2025 -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering...
-
Myriad Genetics will share 11 new research studies highlighting advancements in oncology and reproductive genetic testing at NSGC.